Literature DB >> 33185169

Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice.

Pupalan Iyngkaran1, Merlin Thomas2, John D Horowitz3, Paul Komesaroff4, Michael Jelinek5, David L Hare6.   

Abstract

At least half of all heart failure (CHF) patients will have a comorbidity that could be undertreated, requires additional speciality input and/or polypharmacy. These patients are then at risk of iatrogenic and disease-related complications and readmissions if not closely supervised. Common comorbidities of relevance are cardiorenal and cardiometabolic syndromes (DM, obesity, OSA), chronic airways disease, elderly age, and accompanying pharmacotherapies. The structure of community practice often leaves primary, speciality, and allied health care in silos. For example, cardiology speciality training in Australia creates excellent sub-specialists to deliver diagnostic and therapeutic advances. A casualty of this process has been the gradual alienation of general cardiology toward general internal medical specialists and primary care practitioners. The consequences are largely noticed in community practice. The issue is compounded by suboptimal communication of information. This review explores these issues from a cardiology sub-speciality lens; firstly cross speciality areas that are important for cardiologists to maintain their skill, and finally, to obtain a brief overview of disease management and identify game-changing common denominators such as endothelial dysfunction and self-management. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Comorbidity; cardiometabolic syndrome.; cardiovascular disease; congestive heart failure; disease management; metabolically healthy obesity; obesity; obesity paradox; performance markers; process of care; specialist training

Mesh:

Year:  2021        PMID: 33185169      PMCID: PMC8950452          DOI: 10.2174/1573403X16666201113093548

Source DB:  PubMed          Journal:  Curr Cardiol Rev        ISSN: 1573-403X


  34 in total

1.  Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines-Heart Failure Registry.

Authors:  Abhinav Sharma; Xin Zhao; Bradley G Hammill; Adrian F Hernandez; Gregg C Fonarow; G Michael Felker; Clyde W Yancy; Paul A Heidenreich; Justin A Ezekowitz; Adam D DeVore
Journal:  Circ Heart Fail       Date:  2018-06       Impact factor: 8.790

Review 2.  Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.

Authors:  Andrew Xanthopoulos; Filippos Triposkiadis; Randall C Starling
Journal:  Trends Cardiovasc Med       Date:  2018-01-09       Impact factor: 6.677

3.  Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

Authors:  Benjamin A Steinberg; Xin Zhao; Paul A Heidenreich; Eric D Peterson; Deepak L Bhatt; Christopher P Cannon; Adrian F Hernandez; Gregg C Fonarow
Journal:  Circulation       Date:  2012-05-21       Impact factor: 29.690

4.  Prognostic factors for one-year mortality in patients with acute heart failure with and without chronic kidney disease: differential impact of beta-blocker and diuretic treatments.

Authors:  Kenichi Matsushita; Toshinori Minamishima; Konomi Sakata; Toru Satoh; Hideaki Yoshino
Journal:  Hypertens Res       Date:  2019-01-18       Impact factor: 3.872

5.  Associations between outpatient heart failure process-of-care measures and mortality.

Authors:  Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Mihai Gheorghiade; J Thomas Heywood; Yang Liu; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy
Journal:  Circulation       Date:  2011-04-04       Impact factor: 29.690

Review 6.  Abdominal obesity and metabolic syndrome.

Authors:  Jean-Pierre Després; Isabelle Lemieux
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 7.  Body mass index and mortality in heart failure: a meta-analysis.

Authors:  Antigone Oreopoulos; Raj Padwal; Kamyar Kalantar-Zadeh; Gregg C Fonarow; Colleen M Norris; Finlay A McAlister
Journal:  Am Heart J       Date:  2008-07       Impact factor: 4.749

8.  AUStralian Indigenous Chronic Disease Optimisation Study (AUSI-CDS) prospective observational cohort study to determine if an established chronic disease health care model can be used to deliver better heart failure care among remote Indigenous Australians: Proof of concept-study rationale and protocol.

Authors:  P Iyngkaran; V Majoni; K Nadarajan; M Haste; M Battersby; Marcus Ilton; M Harris
Journal:  Heart Lung Circ       Date:  2013-05-18       Impact factor: 2.975

9.  Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age.

Authors:  Shane Nanayakkara; Mark Haykowsky; Justin Mariani; Vanessa Van Empel; Micha T Maeder; Donna Vizi; David M Kaye
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

Review 10.  Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Shane Nanayakkara; Hitesh C Patel; David M Kaye
Journal:  Clin Med Insights Cardiol       Date:  2018-01-08
View more
  1 in total

1.  Heart Failure Paradigms in the Developed World - A Reflection - Part 1

Authors:  Pupalan Iyngkaran; David L Hare
Journal:  Curr Cardiol Rev       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.